Study guide
Communication, Surrogate Decision-Making & Conflict Resolution
ABPN Neurocritical Care Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU
Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU
2 Chapter 2: Cerebral Physiology & Intracranial Dynamics
Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes
3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management
Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions
4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management
Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy
5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management
Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury
6 Chapter 6: Neuropharmacology, Analgesia & Sedation
ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU
7 Bleeding, Thrombosis & Hematologic Emergencies
Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity
8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine
Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention
9 Systemic Trauma & Environmental Injury
Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging
10 Cardiac Emergencies & Mechanical Support
IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies
11 Kidney Injury, Acid–Base & Renal Replacement
Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement
12 Systemic Infection & Endocrine Emergencies
Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies
13 Gastrointestinal & Hepatic Emergencies
Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects
14 Chapter 9: Neuroimaging in the Neuro-ICU
Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness
15 Chapter 10: Electrophysiology & Neuromonitoring
Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler
16 Angiography, Electrodiagnosis & CSF Analysis
Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage
17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria
Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria
18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies
Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction
19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage
Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH
20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations
21 Venous, Spinal & Traumatic Vascular Disease
Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury
22 Chapter 15: Traumatic Brain & Spinal Cord Injury
Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes
23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies
Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure
24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis
Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies
25 Neuroinflammation & Neurooncology
Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies
26 Pregnancy, Transplantation & Pediatric Care
Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care
27 Chapter 18: Neurosurgical & Perioperative Emergencies
Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies
28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU
Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor
Communication, Surrogate Decision-Making & Conflict Resolution
Key Takeaways Explain This Topic AI
Use clear explanations, active listening, emotional acknowledgment, and checks of understanding during serious-illness conversations.
Capacity is decision-specific and time-specific; address reversible communication and cognitive barriers.
Verify surrogate authority and directive applicability under the relevant law and document; no single national default hierarchy applies.
Use patient preferences, substituted judgment, and best interests appropriately, while distinguishing DNAR from other treatment limits.
Resolve persistent disputes through a fair clinical, ethics, and legal process; ethical guidance does not itself confer universal legal immunity.
Last updated: October 2026
Communication, Surrogate Decision-Making & Conflict Resolution
Catastrophic neurological injury—massive stroke, severe traumatic brain injury ( T B I TBI TB I ), aneurysmal subarachnoid hemorrhage ( a S A H aSAH a S A H ), or hypoxic-ischemic brain injury ( H I B I HIBI H I B I )—abruptly plunges families into psychological crisis without opportunity for emotional preparation. Neurointensivists must navigate acute surrogate grief, high emotional stakes, and complex ethical dilemmas while maintaining clinical rigor and humanistic empathy.
Structured Communication in Devastating Brain Injury
Surrogates of neurocritical care patients face extreme cognitive overload, shock, and anticipatory grief, resulting in acute stress disorder in > 80 % > 80\% > 80% of family members and long-term post-traumatic stress disorder ( P T S D PTSD PTS D ) in over one-third. Unstructured, ad-hoc discussions worsen psychological morbidity and foster adversarial clinician-family dynamics.
The VALUE Framework
A landmark randomized controlled trial by Lautrette et al. ( N Engl J Med 2007) demonstrated that a structured communication strategy combined with a bereavement brochure significantly reduced surrogate anxiety, depression, and PTSD symptoms at 90 days. The VALUE mnemonic defines this proactive approach:
V — Value family statements: Explicitly acknowledge family observations regarding the patient's personality, values, and pre-injury baseline.
A — Acknowledge emotions: Validate intense emotional reactions (e.g., "I can see how overwhelming and heartbreaking this news is for you").
L — Listen to the family: Maintain an intentional listening-to-talking ratio where clinicians spend at least 50 – 80 % 50\text{--}80\% 50 – 80% of conference time listening. Avoid dominating discussions with complex pathophysiological details.
U — Understand the patient as a person: Ask open-ended questions about the patient's identity ("Tell us what your father loved doing," "What brought his days meaning and joy?").
E — Elicit questions: Proactively invite inquiries ("What questions or worries are foremost on your mind right now?").
The SPIKES Protocol for Delivering Bad News
When disclosing devastating neuroimaging findings, brain death, or poor functional recovery, the six-step SPIKES protocol establishes a structured, compassionate foundation:
Step Operational Strategy Clinical Application in Neurocritical Care
S — Setting Secure private space; assemble team; sit down at eye level Ensure bedside nurse, social worker, or chaplain is present; mute pagers and mobile phones.
P — Perception Explore surrogate understanding "What has the neurosurgical team explained so far about the bleeding in her brain?"
I — Invitation Gauge desired depth of information "Would you prefer a broad overview first, or would you like to review the specific scan images?"
K — Knowledge Deliver clear, non-jargon truth with a 'warning shot' "I am afraid the repeat CT scan shows the brain swelling has worsened significantly." Avoid euphemisms.
E — Emotions Respond empathetically using the NURSE framework N ame, U nderstand, R espect, S upport, and E xplore emotions; allow purposeful silence.
S — Strategy & Summary Formulate clear roadmap; summarize next steps Outline structured neurological surveillance milestones or a scheduled time-limited trial.
Mitigating Cognitive Overload
Severe acute stress impairs executive functioning and working memory in surrogates. Neurointensivists should apply information chunking (limiting disclosure to 2–3 key concepts per meeting), utilize simplified graphical illustrations of brain pathology, avoid medical jargon ("transtentorial herniation," "autoregulatory breakthrough"), and execute frequent check-backs ("To make sure I explained the situation clearly, could you tell me what you will share with your family?").
Capacity, Directives, and Surrogates
Decision-making capacity is assessed for a particular decision at a particular time. Evaluate understanding, appreciation, reasoning, and ability to communicate a choice. Address language barriers, hearing impairment, delirium, sedation, pain, and other reversible limitations. Use supported communication and an interpreter when appropriate. A diagnosis of neurologic disease does not automatically remove capacity for every decision. Legal competency and guardianship involve the applicable legal process and can have limited scopes rather than one uniform global meaning.
When capacity is absent, identify the legally authorized decision-maker and any applicable advance directive or medical order. Verify the document, its scope, and whether its conditions apply to the current situation. An early coma does not establish that a directive conditioned on permanent irreversible coma has become operative. A healthcare agent generally represents the patient's wishes rather than personal preferences, but authority, activation, guardian powers, and default-surrogate priorities depend on jurisdiction and the document. There is no single federal sequence of guardian, proxy, spouse, children, and siblings for every US patient.
Use known wishes and values to guide substituted judgment. When preferences are unknown, assess best interests through expected benefits, burdens, suffering, and the patient's circumstances. These ethical standards inform a recommendation; they are not an excuse to project the clinician's view of acceptable disability onto the patient. Clarify distinctions between DNAR, other treatment limits, and comfort-focused care. A DNAR order applies to resuscitation after arrest and does not automatically prohibit antibiotics, surgery, or intensive care.
Conflict Resolution and Uncertainty
Explore what each participant understands and what outcomes matter to the patient. Identify whether disagreement concerns facts, prognosis, religious or cultural commitments, mistrust, or who has authority. Use consistent team communication, professional interpretation, palliative support, ethics consultation, and an independent clinical opinion when appropriate. Equal-priority surrogate disagreements are handled according to applicable law and policy; neither an automatic majority vote nor automatic court guardianship is a universal solution.
Distinguish an intervention that cannot achieve its physiologic objective from a value disagreement about the benefit of an achievable outcome. A pH below a particular number, a severity score, or a severe disability diagnosis alone does not prove physiologic futility. Prolonged unresponsiveness also does not establish zero possibility of recovery without an appropriate assessment. Explain what is known, what remains uncertain, and how confounders and time affect confidence.
AMA ethical guidance supports a fair institutional review process for disputes about medically ineffective interventions, including clarification, consultation, review, and efforts to transfer care when appropriate. It does not create blanket legal immunity or a national permission to withdraw contested support after a fixed 7–14-day period. Any withholding or withdrawal in an unresolved dispute requires compliance with the applicable law, policy, and procedural protections, with ethics and legal counsel involvement. Continue symptom relief and respectful communication throughout the process.
A time-limited trial can make uncertainty manageable. Agree on treatments, a clinically appropriate observation interval, measurable milestones, and a review meeting. The interval depends on the disease and confounders; 48 or 72 hours is not a universal deadline for a final neurologic judgment. Include the possible outcomes and next steps without promising recovery or requiring that every patient achieve command following by the same date. Document the discussion, recommendation, decision-maker, and follow-up plan, and revisit goals when meaningful new information appears.
Source: AMA guidance on medically ineffective interventions .